Antibodies, ELISA kits, research products
Total Trials
1
As Lead Sponsor
0
As Collaborator
Total Enrollment
8
NCT01828762
Autologous Immune Cell Therapy in Primary Hepatocellular Carcinoma Patients Following Resection and TACE Therapy
Phase: N/A
Role: Collaborator
Start: Dec 31, 2012
Completion: Not specified
Loading map...